StockData
Agenus Inc logo

Agenus Inc (AGEN) shareholders

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.21−0.08 (-1.27%)

Close on Nov 17, 2026Market cap $279.58MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
31.7%
14M of 45M shares
Institutional holders
102
31 new, 15 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Raymond Debbane
Joint filing with Invus Public Equities, L.P. (8.80%), Invus Public Equities Advisors, LLC (8.80%) and 2 more
4,533,7559.99%13G (passive)Jul 13, 2026
RA Capital Management, L.P.
Joint filing with Peter Kolchinsky (9.90%), Rajeev Shah (9.90%) and 1 more
4,344,7729.90%13G (passive)Jul 13, 2026
BlackRock, Inc.2,513,8936.00%13G (passive)Jun 30, 2026
Zydus Lifesciences Ltd
Joint filing with Zynext Ventures USA LLC (5.90%), Zynext Ventures Pte Ltd (5.90%)
2,133,3335.90%13D (active)Jan 15, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of AGENValueChange% of portfolio
BlackRock, Inc.2,564,8845.70%$7.85M+2,019,2220.00%
Vanguard Capital Management LLC1,676,0963.72%$5.13M+235,8640.00%
Vanguard Portfolio Management LLC1,427,5873.17%$4.37M+232,4780.00%
Siren, L.L.C.1,064,2502.36%$3.26M–0.07%
Geode Capital Management, LLC1,035,0402.30%$3.17M+686,6450.00%
Mackenzie Financial Corp714,1751.59%$2.19MNew0.00%
Goldman Sachs Group Inc448,3831.00%$1.37M+416,9290.00%
Marshall Wace, Llp439,6210.98%$1.35M−248,5820.00%
Raymond James Financial Inc430,0780.96%$1.32M+190,5240.00%
Globeflex Capital L P418,5810.93%$1.28MNew0.16%
State Street Corp412,3830.92%$1.26M+256,2000.00%
Man Group plc340,4250.76%$1.04M+61,4450.00%
Northern Trust Corp314,0520.70%$961.00K+224,3320.00%
Connor, Clark & Lunn Investment Management Ltd.310,0350.69%$948.71K+111,5330.00%
Vanguard Fiduciary Trust Co271,6140.60%$831.14K+71,1160.00%
Morgan Stanley262,0680.58%$801.93K−33,7530.00%
Renaissance Technologies LLC228,3460.51%$698.74K−57,3000.00%
Panagora Asset Management Inc179,5890.40%$549.54K+16,4410.00%
Susquehanna Portfolio Strategies, LLC158,7370.35%$485.74KNew0.01%
Jump Financial, LLC103,9810.23%$318.18K−53,2190.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202610214M31.7%31 / 3218 / 157M2M
Q1 2026879M20.5%13 / 1532 / 204M2M
Q4 20259610M22.5%22 / 2530 / 103M1M
Q3 2025879M19.6%21 / 2028 / 242M2M
Q2 2025919M19.9%33 / 1928 / 293M3M
Q1 2025889M19.7%18 / 2226 / 142M1M
Q4 2024848M18.7%17 / 2719 / 302M2M
Q3 2024978M18.6%32 / 2722 / 214M3M
Q2 2024889M19.7%84 / 12 / 59M0M
Q1 2024100M0.1%10 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

63 funds held AGEN in Q2 2026, 61% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of AGENValue% of fundAs of
Vanguard Total Stock Market Index Fund1,159,6722.58%$3.55M0.00%Jun 30, 2026
iShares Russell 2000 ETF903,7112.01%$2.77M0.00%Jun 30, 2026
Vanguard Strategic Equity Fund511,8091.14%$1.57M0.01%Jun 30, 2026
Vanguard Extended Market Index Fund485,1581.08%$1.48M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund435,9520.97%$3.27M0.01%Jul 31, 2026
Vanguard Explorer Fund290,6460.65%$2.18M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF258,4550.57%$790.87K0.01%Jun 30, 2026
iShares Russell 2000 Growth ETF256,8420.57%$785.94K0.01%Jun 30, 2026
Vanguard Strategic Small-Cap Equity Fund205,3450.46%$628.36K0.02%Jun 30, 2026
Fidelity Extended Market Index Fund163,9210.36%$573.72K0.00%May 31, 2026
iShares Micro-Cap ETF133,9840.30%$409.99K0.03%Jun 30, 2026
Small Company Growth Portfolio114,7470.25%$351.13K0.02%Jun 30, 2026
Schwab Small-Cap Index Fund96,3100.21%$722.33K0.01%Jul 31, 2026
Siit Small Cap Ii Fund84,7000.19%$296.45K0.12%May 31, 2026
Master Small Cap Index Series74,4800.17%$227.91K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Garo H. ArmenSee Remarks, Director402,4060.89%Aug 12, 2026
Jennifer BuellSee Remarks, Director19,7380.04%Aug 7, 2026
Steven J. O'DayChief Medical Officer57,1160.13%Aug 7, 2026
Austin CharettePrincipal Accounting Officer9,1150.02%Apr 28, 2026
Christine M. KlaskinPFO & PAO23,5100.05%Jun 30, 2025
Timothy WrightDirector55,3910.12%Oct 2, 2026
Thomas L. HarrisonDirector51,9880.12%Oct 2, 2026
Marco Tullio MarcucciDirector5,4800.01%Sep 16, 2026
Brian CorveseDirector92,0850.20%Aug 11, 2026
Susan B. HirschDirector118,7250.26%Aug 7, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Thomas L. Harrison
Director
Oct 1, 2026Award+4,443$6.89$30.63K51,988
Garo H. Armen
See Remarks, Director
Jul 10, 2026Award+4,852$3.35$16.25K371,108
Thomas L. Harrison
Director
Jul 1, 2026Award+8,547$3.58$30.60K47,545
Garo H. Armen
See Remarks, Director
Jun 26, 2026Award+5,364$3.03$16.25K366,256
Garo H. Armen
See Remarks, Director
Jun 12, 2026Award+4,925$3.30$16.25K360,892
Garo H. Armen
See Remarks, Director
May 29, 2026Award+4,644$3.50$16.25K355,967
Garo H. Armen
See Remarks, Director
May 15, 2026Award+4,540$3.58$16.25K351,323
Garo H. Armen
See Remarks, Director
May 1, 2026Award+4,233$3.84$16.25K346,783
Garo H. Armen
See Remarks, Director
Apr 17, 2026Award+3,403$4.79$16.30K342,550
Garo H. Armen
See Remarks, Director
Apr 3, 2026Award+4,629$3.33$15.41K339,147
Thomas L. Harrison
Director
Apr 1, 2026Award+9,228$3.32$30.64K38,998
Garo H. Armen
See Remarks, Director
Mar 20, 2026Award+3,983$3.71$14.78K334,518
Garo H. Armen
See Remarks, Director
Mar 6, 2026Award+4,994$2.96$14.78K330,535
Garo H. Armen
See Remarks, Director
Feb 20, 2026Award+4,829$3.06$14.78K325,541
Garo H. Armen
See Remarks, Director
Feb 6, 2026Award+5,027$2.94$14.78K320,712
Garo H. Armen
See Remarks, Director
Jan 23, 2026Award+4,562$3.24$14.78K315,685
Garo H. Armen
See Remarks, Director
Jan 9, 2026Award+3,780$3.91$14.78K311,123
Thomas L. Harrison
Director
Jan 2, 2026Award+7,691$3.98$30.61K29,770
Garo H. Armen
See Remarks, Director
Dec 26, 2025Award+4,942$3.31$16.36K307,343
Garo H. Armen
See Remarks, Director
Dec 12, 2025Award+4,316$3.79$16.36K302,401
Garo H. Armen
See Remarks, Director
Nov 28, 2025Award+3,587$4.56$16.36K298,085
Garo H. Armen
See Remarks, Director
Nov 14, 2025Award+3,769$4.34$16.36K294,498
Garo H. Armen
See Remarks, Director
Oct 31, 2025Award+4,120$3.97$16.36K290,729
Garo H. Armen
See Remarks, Director
Oct 17, 2025Award+4,216$3.88$16.36K286,609
Garo H. Armen
See Remarks, Director
Oct 3, 2025Award+3,951$4.14$16.36K282,393
Thomas L. Harrison
Director
Oct 1, 2025Award+5,780$5.01$28.96K22,079
Garo H. Armen
See Remarks, Director
Sep 19, 2025Award+3,734$4.38$16.35K278,442
Garo H. Armen
See Remarks, Director
Sep 5, 2025Award+3,778$4.33$16.36K274,708
Garo H. Armen
See Remarks, Director
Aug 22, 2025Award+3,619$4.52$16.36K270,930
Garo H. Armen
See Remarks, Director
Aug 8, 2025Award+3,407$4.80$16.35K267,311
Garo H. Armen
See Remarks, Director
Jul 25, 2025Award+2,745$5.96$16.36K263,904
Garo H. Armen
See Remarks, Director
Jul 11, 2025Award+2,317$7.06$16.36K261,159
Thomas L. Harrison
Director
Jul 1, 2025Award+7,401$3.46$25.61K16,299
Garo H. Armen
See Remarks, Director
Jun 27, 2025Award+3,436$4.76$16.36K258,842
Steven J. O'Day
Chief Medical Officer
Jun 18, 2025Award+43,497$4.47$194.43K57,116
Garo H. Armen
See Remarks, Director
Jun 18, 2025Award+61,397$4.47$274.44K255,406
Christine M. Klaskin
PFO & PAO
Jun 18, 2025Award+15,782$4.47$70.55K23,478
Garo H. Armen
See Remarks, Director
Jun 13, 2025Award+3,480$4.70$16.36K194,009
Garo H. Armen
See Remarks, Director
May 30, 2025Award+4,769$3.43$16.36K190,529
Garo H. Armen
See Remarks, Director
May 16, 2025Award+4,700$3.48$16.36K185,750
Jennifer Buell
Director
May 2, 2025Award+581$3.11$1.81K19,738
Garo H. Armen
See Remarks, Director
May 2, 2025Award+5,260$3.11$16.36K181,060
Jennifer Buell
Director
Apr 18, 2025Award+869$2.08$1.81K19,157
Garo H. Armen
See Remarks, Director
Apr 18, 2025Award+7,886$2.08$16.40K175,800
Jennifer Buell
Director
Apr 4, 2025Award+1,159$1.56$1.81K18,288
Garo H. Armen
See Remarks, Director
Apr 4, 2025Award+10,288$1.56$16.05K167,914
Thomas L. Harrison
Director
Apr 1, 2025Award+8,898$2.88$25.63K8,898
Jennifer Buell
Director
Mar 21, 2025Award+1,123$1.61$1.81K17,129
Garo H. Armen
See Remarks, Director
Mar 21, 2025Award+9,243$1.61$14.88K157,626
Jennifer Buell
Director
Mar 7, 2025Award+409$2.35$96115,646
Garo H. Armen
See Remarks, Director
Mar 7, 2025Award+6,332$2.35$14.88K148,383
Jennifer Buell
Director
Feb 21, 2025Award+545$3.32$1.81K15,237
Jennifer Buell
Director
Feb 21, 2025Award+626$3.32$2.08K15,318
Garo H. Armen
See Remarks, Director
Feb 21, 2025Award+4,483$3.32$14.88K142,051
Jennifer Buell
Director
Feb 7, 2025Award+516$3.50$1.81K14,692
Garo H. Armen
See Remarks, Director
Feb 7, 2025Award+4,251$3.50$14.88K137,568
Jennifer Buell
Director
Jan 24, 2025Tax withholding−270$3.57$96414,176
Garo H. Armen
See Remarks, Director
Jan 24, 2025Award+4,169$3.57$14.88K133,317
Jennifer Buell
Director
Jan 24, 2025Award+776$3.57$2.77K14,446
Garo H. Armen
See Remarks, Director
Jan 10, 2025Award+4,777$3.12$14.90K129,148

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
18.06%
8M shares short
Days to cover
10.7
At 1M shares a day
Change since last report
+8.5%
From 7M shares
Short volume, 20 days
52.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Agenus's stock actually held short. Settlement fails (shares not delivered on time) peaked at 12,465 shares on Sep 11, 2026 over the last 90 days.

See a number that looks wrong?